Carboxytherapy  ||| S:0 E:15 ||| NNP
-  ||| S:15 E:17 ||| :
supportive  ||| S:17 E:28 ||| JJ
therapy  ||| S:28 E:36 ||| NN
in  ||| S:36 E:39 ||| IN
chronic  ||| S:39 E:47 ||| JJ
wound  ||| S:47 E:53 ||| NN
treatment  ||| S:53 E:63 ||| NN
Carboxytherapy  ||| S:63 E:78 ||| NNP
is  ||| S:78 E:81 ||| VBZ
a  ||| S:81 E:83 ||| DT
supportive  ||| S:83 E:94 ||| JJ
method  ||| S:94 E:101 ||| NN
in  ||| S:101 E:104 ||| IN
chronic  ||| S:104 E:112 ||| JJ
wound  ||| S:112 E:118 ||| NN
treatment  ||| S:118 E:128 ||| NN
conducted  ||| S:128 E:138 ||| VBN
by  ||| S:138 E:141 ||| IN
cutaneous  ||| S:141 E:151 ||| NN
and  ||| S:151 E:155 ||| CC
subcutaneous  ||| S:155 E:168 ||| JJ
injection  ||| S:168 E:178 ||| NN
of  ||| S:178 E:181 ||| IN
medical  ||| S:181 E:189 ||| JJ
carbon  ||| S:189 E:196 ||| NN
dioxide  ||| S:196 E:204 ||| NN
( ||| S:204 E:205 ||| -LRB-
CO2 ||| S:205 E:208 ||| NNP
) ||| S:208 E:209 ||| -RRB-
.  ||| S:209 E:211 ||| .
The  ||| S:211 E:215 ||| DT
primary  ||| S:215 E:223 ||| JJ
effect  ||| S:223 E:230 ||| NN
of  ||| S:230 E:233 ||| IN
the  ||| S:233 E:237 ||| DT
injected  ||| S:237 E:246 ||| JJ
CO2  ||| S:246 E:250 ||| NN
is  ||| S:250 E:253 ||| VBZ
the  ||| S:253 E:257 ||| DT
correction  ||| S:257 E:268 ||| NN
of  ||| S:268 E:271 ||| IN
tissue  ||| S:271 E:278 ||| NN
hypoxia  ||| S:278 E:286 ||| VBZ
due  ||| S:286 E:290 ||| JJ
to  ||| S:290 E:293 ||| TO
the  ||| S:293 E:297 ||| DT
Bohr  ||| S:297 E:302 ||| JJ
effect ||| S:302 E:308 ||| NN
.  ||| S:308 E:310 ||| .
With  ||| S:310 E:315 ||| IN
its  ||| S:315 E:319 ||| PRP$
effects  ||| S:319 E:327 ||| NNS
on  ||| S:327 E:330 ||| IN
endothelial  ||| S:330 E:342 ||| JJ
growth  ||| S:342 E:349 ||| NN
factors ||| S:349 E:356 ||| NNS
,  ||| S:356 E:358 ||| ,
it  ||| S:358 E:361 ||| PRP
stimulates  ||| S:361 E:372 ||| VBP
neoangiogenesis  ||| S:372 E:388 ||| VBN
and  ||| S:388 E:392 ||| CC
fibroblast  ||| S:392 E:403 ||| JJ
collagen  ||| S:403 E:412 ||| NN
synthesis  ||| S:412 E:422 ||| VBZ
consequently  ||| S:422 E:435 ||| RB
leading  ||| S:435 E:443 ||| VBG
to  ||| S:443 E:446 ||| TO
better  ||| S:446 E:453 ||| JJR
wound  ||| S:453 E:459 ||| NN
healing ||| S:459 E:466 ||| NN
.  ||| S:466 E:468 ||| .
Carboxytherapy  ||| S:468 E:483 ||| NNP
is  ||| S:483 E:486 ||| VBZ
used  ||| S:486 E:491 ||| VBN
in  ||| S:491 E:494 ||| IN
many  ||| S:494 E:499 ||| JJ
areas  ||| S:499 E:505 ||| NNS
from  ||| S:505 E:510 ||| IN
chronic  ||| S:510 E:518 ||| JJ
wound  ||| S:518 E:524 ||| NN
treatment ||| S:524 E:533 ||| NN
,  ||| S:533 E:535 ||| ,
peripheral  ||| S:535 E:546 ||| JJ
venous  ||| S:546 E:553 ||| NN
and  ||| S:553 E:557 ||| CC
arterial  ||| S:557 E:566 ||| JJ
diseases ||| S:566 E:574 ||| NNS
,  ||| S:574 E:576 ||| ,
dermatological  ||| S:576 E:591 ||| JJ
diseases ||| S:591 E:599 ||| NNS
,  ||| S:599 E:601 ||| ,
to  ||| S:601 E:604 ||| TO
cosmetic  ||| S:604 E:613 ||| JJ
medicine ||| S:613 E:621 ||| NN
.  ||| S:621 E:623 ||| .
It  ||| S:623 E:626 ||| PRP
is  ||| S:626 E:629 ||| VBZ
minimally  ||| S:629 E:639 ||| JJ
invasive ||| S:639 E:647 ||| NN
,  ||| S:647 E:649 ||| ,
patients  ||| S:649 E:658 ||| NNS
take  ||| S:658 E:663 ||| VBP
it  ||| S:663 E:666 ||| PRP
well ||| S:666 E:670 ||| RB
,  ||| S:670 E:672 ||| ,
it  ||| S:672 E:675 ||| PRP
is  ||| S:675 E:678 ||| VBZ
economically  ||| S:678 E:691 ||| RB
acceptable ||| S:691 E:701 ||| JJ
,  ||| S:701 E:703 ||| ,
and  ||| S:703 E:707 ||| CC
it  ||| S:707 E:710 ||| PRP
can  ||| S:710 E:714 ||| MD
be  ||| S:714 E:717 ||| VB
conducted  ||| S:717 E:727 ||| VBN
in  ||| S:727 E:730 ||| IN
outpatient  ||| S:730 E:741 ||| JJ
conditions  ||| S:741 E:752 ||| NNS
by  ||| S:752 E:755 ||| IN
properly  ||| S:755 E:764 ||| RB
trained  ||| S:764 E:772 ||| VBN
doctors ||| S:772 E:779 ||| NNS
.  ||| S:779 E:781 ||| .
The  ||| S:781 E:785 ||| DT
application  ||| S:785 E:797 ||| NN
of  ||| S:797 E:800 ||| IN
new  ||| S:800 E:804 ||| JJ
technologic  ||| S:804 E:816 ||| JJ
innovations  ||| S:816 E:828 ||| NNS
in  ||| S:828 E:831 ||| IN
the  ||| S:831 E:835 ||| DT
healing  ||| S:835 E:843 ||| NN
processes ||| S:843 E:852 ||| NNS
,  ||| S:852 E:854 ||| ,
education  ||| S:854 E:864 ||| NN
and  ||| S:864 E:868 ||| CC
teamwork  ||| S:868 E:877 ||| VB
combined  ||| S:877 E:886 ||| VBN
with  ||| S:886 E:891 ||| IN
developed  ||| S:891 E:901 ||| VBN
holistic  ||| S:901 E:910 ||| JJ
individual  ||| S:910 E:921 ||| JJ
approach  ||| S:921 E:930 ||| NN
ensure  ||| S:930 E:937 ||| VB
good  ||| S:937 E:942 ||| JJ
cooperation  ||| S:942 E:954 ||| NN
and  ||| S:954 E:958 ||| CC
mutual  ||| S:958 E:965 ||| JJ
doctor-patient  ||| S:965 E:980 ||| JJ
communication ||| S:980 E:993 ||| NN
,  ||| S:993 E:995 ||| ,
enhance  ||| S:995 E:1003 ||| VB
patient  ||| S:1003 E:1011 ||| JJ
care  ||| S:1011 E:1016 ||| NN
and  ||| S:1016 E:1020 ||| CC
improve  ||| S:1020 E:1028 ||| VB
their  ||| S:1028 E:1034 ||| PRP$
quality  ||| S:1034 E:1042 ||| NN
of  ||| S:1042 E:1045 ||| IN
life ||| S:1045 E:1049 ||| NN
.  ||| S:1049 E:1051 ||| .
